Literature DB >> 12595383

Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study.

E Løkkegaard1, A T Pedersen, B L Heitmann, Z Jovanovic, N Keiding, Y A Hundrup, E B Obel, B Ottesen.   

Abstract

OBJECTIVE: To investigate the risk of ischaemic heart disease and myocardial infarction among women using hormone replacement therapy, especially the potential modifying effect of cardiovascular risk factors.
DESIGN: Prospective observational study.
SETTING: Denmark. PARTICIPANTS: 19 898 nurses aged 45 and over completing a questionnaire on lifestyle and use of hormone replacement therapy in 1993. MAIN OUTCOME MEASURES: All cases of death and incident cases of ischaemic heart disease and myocardial infarction until the end of 1998.
RESULTS: Current users of hormone replacement therapy smoked more, consumed more alcohol, had lower self rated health, but were slimmer and had a lower prevalence of diabetes than never users. In current users compared with never users, hormone replacement therapy had no protective effect on ischaemic heart disease (hazard ratio 1.2, 0.9 to 1.7) or myocardial infarction (1.0, 0.6 to 1.7), whereas current users with diabetes had an increased risk of death (3.2, 1.4 to 7.5), ischaemic heart disease (4.2, 1.4 to 12.5), and myocardial infarction (9.2, 2.0 to 41.4) compared with never users with diabetes.
CONCLUSION: Hormone replacement therapy showed no protective effect on ischaemic heart disease, but there was a significantly increased risk of death from all causes and ischaemic heart disease among women with diabetes.

Entities:  

Mesh:

Year:  2003        PMID: 12595383      PMCID: PMC149444          DOI: 10.1136/bmj.326.7386.426

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

1.  Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes.

Authors:  K E Friday; C Dong; R U Fontenot
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

2.  Lifestyle factors and choice of hormone replacement therapy among Danish nurses.

Authors:  Yrsa A Hundrup; Henrik Thoning; Erik B Obel; Niels K Rasmussen; John Philip
Journal:  Scand J Public Health       Date:  2002       Impact factor: 3.021

3.  Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden.

Authors:  K Rödström; C Bengtsson; L Lissner; C Björkelund
Journal:  BMJ       Date:  1999-10-02

4.  Vascular effects of estrogen in type II diabetic postmenopausal women.

Authors:  K K Koh; M H Kang; D K Jin; S K Lee; J Y Ahn; H Y Hwang; S H Yang; D S Kim; T H Ahn; E K Shin
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

5.  Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women.

Authors:  F B Hu; M J Stampfer; J E Manson; F Grodstein; G A Colditz; F E Speizer; W C Willett
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

6.  Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial.

Authors:  C Cornu; C Mercier; P Ffrench; C Bully; M Pugeat; P Cousin; J P Riou; L Bajart; J Orgiazzi; C Pommet-Nicot; P Darsy; J P Boissel; F Berthezène
Journal:  Maturitas       Date:  2000-12-29       Impact factor: 4.342

7.  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

Authors:  D M Herrington; D M Reboussin; K B Brosnihan; P C Sharp; S A Shumaker; T E Snyder; C D Furberg; G J Kowalchuk; T D Stuckey; W J Rogers; D H Givens; D Waters
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

8.  Use of hormone replacement therapy among Danish nurses in 1993.

Authors:  Y A Hundrup; E B Obel; N K Rasmussen; J Philip
Journal:  Acta Obstet Gynecol Scand       Date:  2000-03       Impact factor: 3.636

9.  Hormone replacement therapy and glucose metabolism.

Authors:  R J Triusu; C C Cowie; M I Harris
Journal:  Obstet Gynecol       Date:  2000-11       Impact factor: 7.661

10.  A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

Authors:  F Grodstein; J E Manson; G A Colditz; W C Willett; F E Speizer; M J Stampfer
Journal:  Ann Intern Med       Date:  2000-12-19       Impact factor: 25.391

View more
  6 in total

Review 1.  Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.

Authors:  Susan E Bromley; Corinne S de Vries; Dawn Thomas; Richard D T Farmer
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Steen Zabell Abildstrøm; Casper Haslund Jørgensen; Rikke Sørensen; Morten Lock Hansen; Tina Ken Schramm; Ellen Løkkegaard; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

3.  Doctor, should I take hormones?

Authors:  Laura Kale
Journal:  Perm J       Date:  2005

4.  What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?

Authors:  Eli Marcelo Lakryc; Rogério Bonassi Machado; José Maria Soares; César Eduardo Fernandes; Edmund Chada Baracat
Journal:  Clinics (Sao Paulo)       Date:  2015-02       Impact factor: 2.365

Review 5.  Menopause care for obese and diabetic women.

Authors:  J Verhaeghe
Journal:  Facts Views Vis Obgyn       Date:  2009

Review 6.  [Progress in the prevention of type 2 diabetes].

Authors:  Guntram Schernthaner
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 2.275

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.